PMEPA1
Protein TMEPAI
Also known as: PMEPA_HUMAN, STAG1, TMEPAI
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969W9
- Gene
- PMEPA1
- Ensembl
- ENSG00000124225
- Chromosome
- 20
- Canonical length
- 287 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Vesicles
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a transmembrane protein that contains a Smad interacting motif (SIM). Expression of this gene is induced by androgens and transforming growth factor beta, and the encoded protein suppresses the androgen receptor and transforming growth factor beta signaling pathways though interactions with Smad proteins. Overexpression of this gene may play a role in multiple types of cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
287 residues, UniProt reviewed canonical sequence.
>Q969W9|PMEPA1
1 MHRLMGVNST AAAAAGQPNV SCTCNCKRSL FQSMEITELE FVQIIIIVVV MMVMVVVITC
61 LLSHYKLSAR SFISRHSQGR RREDALSSEG CLWPSESTVS GNGIPEPQVY APPRPTDRLA
121 VPPFAQRERF HRFQPTYPYL QHEIDLPPTI SLSDGEEPPP YQGPCTLQLR DPEQQLELNR
181 ESVRAPPNRT IFDSDLMDSA RLGGPCPPSS NSGISATCYG SGGRMEGPPP TYSEVIGHYP
241 GSSFQHQQSS GPPSLLEGTR LHHTHIAPLE SAAIWSKEKD KQKGHPLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PMEPA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 128 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 128 nTPM
- prostate: 103 nTPM
- cervix: 88 nTPM
- adipose tissue: 47 nTPM
- basal ganglia: 47 nTPM
- endometrium: 41 nTPM
Single-cell type
- pancreatic duct cells: 905 nCPM
- prostatic glandular cells: 765 nCPM
- müller glia: 477 nCPM
- schwann cells: 459 nCPM
- alveolar cells type 1: 339 nCPM
- salivary basal cells: 297 nCPM
Immune cell
- plasmacytoid DC: 24 nTPM
- naive B-cell: 6.3 nTPM
- memory B-cell: 2.6 nTPM
- naive CD4 T-cell: 1.8 nTPM
- naive CD8 T-cell: 1.2 nTPM
- memory CD4 T-cell: 0.8 nTPM
Brain region
- basal ganglia: 173 nTPM
- pons: 99 nTPM
- cerebellum: 98 nTPM
- thalamus: 94 nTPM
- midbrain: 90 nTPM
- medulla oblongata: 85 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.94
- gnomAD missense Z
- 1.21
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- androgen receptor signaling pathway
- negative regulation of SMAD protein signal transduction
- negative regulation of transforming growth factor beta receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PMEPA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PMEPA1 as an antibody target. Whether an autoantibody or antibody against PMEPA1 could matter depends on whether native PMEPA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PMEPA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PMEPA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...